Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mesenchymal Stromal Cells for Graft-versus-Host Disease: A Trilogy

7 Mar 2020

Abstract excerpt

This issue of the journal showcases 3 clinical trials [1-3], each focused on testing the utility of industrially sourced culture-adapted allogeneic mesenchymal stromal cells (MSCs; remestemcel-L) as a transfusion product to improve the outcome of steroid-refractory acute graft-versus-host disease (GHVD).

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Electrospun Nanofibers in Biomedical Applications
Share to Mesenchymal stem cell research
Share to Tissue Engineering and Regenerative Medicine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32156632
DOI: 10.1016/j.bbmt.2020.02.023

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mesenchymal Stromal Cells for Graft-versus-Host Disease: A TrilogyPMID 32156632Read ↗

Mesenchymal Stem/Stromal Cells: A Review for Its Use After Allogeneic Hematopoietic Stem Cell TransplantationSemantic proximity Read ↗

Adult human mesenchymal stromal cells and the treatment of graft versus host diseaseSemantic proximity Read ↗

Mesenchymal Stem Cells for Therapeutic PurposesSemantic proximity Read ↗

Heterogeneity in Studies of Mesenchymal Stromal Cells to Treat or Prevent Graft-versus-Host Disease: A Scoping Review of the EvidenceSemantic proximity Read ↗

Making the Switch: Alternatives to Fetal Bovine Serum for Adipose-Derived Stromal Cell ExpansionSemantic proximity Read ↗

Emerging novel therapies for steroid-refractory acute graft-versus-host disease: recent advances and future directionsSemantic proximity Read ↗

Multicentre comparison of biological and functional properties of mesenchymal stromal cells from different sources cultivated using a harmonised manufacturing workflowSemantic proximity Read ↗

Concise Review: No Breakthroughs for Human Mesenchymal and Embryonic Stem Cell Culture: Conditioned Medium, Feeder Layer, or Feeder‐Free; Medium with Fetal Calf Serum, Human Serum, or Enriched Plasma; Serum‐Free, Serum Replacement Nonconditioned Medium, or Ad Hoc Formula? All That Glitters Is Not Gold!Semantic proximity Read ↗

Harmonised culture procedures minimise but not eliminate mesenchymal stromal cell donor and tissue variability in a decentralized multicentre manufacturing approachSemantic proximity Read ↗

Characterization of mesenchymal stromal cells: potency assay developmentSemantic proximity Read ↗

Long-Term Follow-Up of a Pilot Study Using Placenta-Derived Decidua Stromal Cells for Severe Acute Graft-versus-Host DiseaseSemantic proximity Read ↗

Safety of Allogeneic Mesenchymal Stromal Cell Therapy Across Human Clinical Indications: A Systematic Review of Landmark Clinical Trials and Published Safety EvidenceSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.